AACR Science Policy and Government Affairs Office

AACR Applauds FDA’s New Steps to Address Epidemic of Youth E-cigarette Use

In 2017, electronic cigarettes (e-cigarettes) were the most commonly used tobacco product among high and middle school students. Many public health experts believe that youth use of e-cigarettes has reached an epidemic proportion.

On September 12, 2018, the U.S. Food and Drug Administration (FDA) announced a series of critical and historic enforcement actions related to the sale and marketing of e-cigarettes to kids. This effort included issuing more than 1,300 warning letters and fines to retailers who illegally sold e-cigarette products to minors.

Read More

FDA Workshop to Address Need for Non-clinical Models to Advance Immuno-oncology

Immuno-oncology has revolutionized treatment for certain types of cancers, but currently it is only effective for about 20 percent of cancer patients. To drive the development of safe and effective immunotherapies for all patients, we need strong science at every stage of drug development, particularly in combination therapy. To this end, refining existing non-clinical models or developing new ones to assess the safety of immuno-oncology products will require cross-sector collaboration among regulatory, industry, and academic experts. The upcoming FDA-AACR Non-clinical Models for Safety Assessment of Immuno-oncology Products Workshop will bring these stakeholders together to discuss this vital issue.

Read More

AACR Holds Congressional Briefing on Strengthening Prevention of E-Cigarette Use in Youth

US Capitol Building

Policymakers, parents, teachers, and public health professionals have all expressed concern about the rise in teen vaping and a strong desire to find ways to reverse the trend. On Wednesday, the American Association for Cancer Research held a congressional briefing to update policymakers and the public on the latest scientific evidence related to e-cigarettes and to start a dialogue about challenges and potential solutions in prevention of youth vaping.

Read More

Joint Workshop to Address Lack of Drug-Radiotherapy Combinations

The field of medical oncology is undergoing a remarkable transformation. Cancers that were once considered death sentences, such as multiple myeloma and metastatic melanoma, are turning into chronic diseases due to the use of novel, targeted systemic therapies. Immunotherapy is altering the natural history of certain malignancies.

Read More

Holding Tobacco Companies Accountable for Deceptive Ads

The relationship between cigarette smoking and lung cancer was first brought to the public’s attention more than 50 years ago, when the U.S. Surgeon General’s report on “Smoking and Health” was published. However, tobacco companies are only now telling the truth about their deadly products, and only thanks to a 2006 court order that they spent more than a decade trying to overturn.

Read More

A Young Researcher Advocates for Strong Federal Funding

Scientific advancements are made through scientific research. From understanding the basic biology behind a disease to testing how well a drug targets a disease, the majority of this research is funded by the National Institutes of Health (NIH). So, on September 14, 2017, hundreds of people from 37 states and Washington, D.C., from over 300 institutes and organizations, gathered for the 5th Annual Rally for Medical Research with a common message

Read More

Scientist↔Survivor Program Participants Spend a Memorable Day on Capitol Hill

US Capitol Building

May is National Cancer Research Month, and for the past 10 years, leaders and members from the American Association for Cancer Research (AACR), the Association of American Cancer Institutes (AACI), and the American Society of Clinical Oncology (ASCO) have converged on Capitol Hill during May to share how cancer research is saving lives and transforming patient care.

Read More

Congressman Advocates for Increased Funding for Cancer Research and Prevention

Last month, U.S. Rep. Donald Payne Jr. (D-New Jersey), led a roundtable discussion at University Hospital in Newark, New Jersey, titled “Cancer Research Today: Innovation, Progress and Promise.” Payne shared his family’s history as part of an effort to increase awareness about colorectal cancer screening.

Read More